Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients

NCT03047772 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
Stem Cell Transplantation
Angioplasty, Transluminal, Percutaneous Coronary

Interventions

DRUG: Atorvastatin
DRUG: Intensive Atorvastatin
DRUG: Low dose BMMSC
DRUG: Middle dose BMMSC
DRUG: High dose BMMSC
DRUG: Transplantation

Sponsor

Yuejin Yang

Collaborators

[object Object]
[object Object]
[object Object]